The Department of State (DOS) will hold a meeting to discuss the implications of Access and Benefit-Sharing (ABS) regimes on global health and biomedical research. In particular, DOS will focus on the effects of Nagoya Protocol and other ABS implementation on public health systems. This is the seconf of two meetings on this topic; the first meeting will occur on June 25, 2019.
Specific issues of focus include: International research collaborations, international pathogen sample sharing, infectious disease research, including influenza, Zika and other diseases, pandemic and epidemic preparedness and response, medical countermeasure product development efforts, investor interest in vaccine development, and other aspects.
DOS would also welcome views on what the World Health Organization, other United Nations bodies, and non-governmental organizations can do to effectively protect public health equities in the context of the Nagoya Protocol and other national level ABS implementation. DOS also welcomes examples of:
- Monetary or non-monetary benefits to the global public health system that are facilitated by international sharing of pathogens, biospecimens, pathogen genetic sequence data, and/or relevant metadata.
- Influenza-specific issues and/or examples related to the items described above or other items that could affect global influenza pandemic preparedness and response or efforts to combat seasonal influenza.
- Non-ABS challenges and barriers with sharing pathogens internationally or that otherwise have significant implications for global pandemic or epidemic preparedness and response efforts that might merit additional attention or analysis.
Members of the public may attend in person. More information is available at this Federal Register notice and at this DOS website.